What are the indications, dosing regimens, and contraindications for N‑acetylcysteine (NAC) in acetaminophen overdose, respiratory conditions, and contrast‑induced nephropathy?

N-Acetylcysteine (NAC): Clinical Indications and Evidence-Based Recommendations

Acetaminophen Overdose: Primary Indication with Strong Evidence

NAC is the definitive antidote for acetaminophen overdose and should be administered immediately when indicated, with maximal benefit when started within 8-10 hours of ingestion. 1, 2

When to Administer NAC in Acetaminophen Overdose

Acute Single Ingestion with Known Timing:

• Administer NAC when serum acetaminophen levels plot in the "possible risk" or "probable risk" zones on the Rumack-Matthew nomogram (levels drawn 4-24 hours post-ingestion) 1, 2
• Treatment within 8 hours results in only 2.9% severe hepatotoxicity, compared to 26.4% when treated after 10 hours 2
• Early treatment virtually eliminates severe hepatotoxicity risk 2

Cannot Use Nomogram (Administer NAC in ALL these scenarios):

• Presentation >24 hours after ingestion 2
• Unknown or unreliable time of ingestion 2
• Extended-release acetaminophen formulations 2
• Repeated supratherapeutic ingestions (>4g per 24 hours over multiple days) 1, 2
• Established acute liver failure with suspected acetaminophen involvement, even without confirmatory history 2

High-Risk Populations (Lower Treatment Threshold):

• Chronic alcohol users, fasting patients, or those on enzyme-inducing medications may develop toxicity at lower acetaminophen levels and should receive NAC even below typical treatment thresholds 2

NAC Dosing Regimens for Acetaminophen Overdose

Oral Protocol (Traditional):

• Loading dose: 140 mg/kg orally
• Maintenance: 70 mg/kg every 4 hours for 17 additional doses (total 72-hour protocol) 2

Intravenous Protocol (Preferred for severe cases):

• Loading dose: 150 mg/kg IV over 15 minutes
• Second dose: 50 mg/kg IV over 4 hours
• Third dose: 100 mg/kg IV over 16 hours 2

Critical Timing Considerations:

• Do not delay NAC while awaiting confirmatory acetaminophen levels if strong clinical suspicion exists 2
• NAC reduces mortality in fulminant hepatic failure from 80% to 52% 2
• Treatment delays beyond 10 hours result in 53% severe hepatotoxicity with 5% mortality 2

Special Considerations for Acetaminophen Overdose

• Activated charcoal may be given within 4 hours of ingestion but should not delay NAC administration 2
• For established hepatic failure, IV NAC is required regardless of time since ingestion 2
• Extended-release formulations require standard dosing but may need extended monitoring 2

---

Contrast-Induced Nephropathy: NAC is NOT Recommended

NAC should NOT be used for prevention of contrast-induced nephropathy—high-quality evidence demonstrates no benefit, and major cardiology guidelines explicitly recommend against its use. 1, 3, 4

Definitive Evidence Against NAC for Contrast Prophylaxis

Highest Quality Evidence:

• The ACT trial (2,308 patients) showed identical contrast-induced AKI rates of 12.7% in both NAC and placebo groups 1
• The American College of Cardiology/American Heart Association states NAC administration is "not useful" for contrast-induced AKI prevention (Class III: No Benefit, Level A evidence) 1
• Meta-analysis of high-quality trials showed no effect (RR 1.05; 95% CI 0.73-1.53) 1, 4

Why Earlier Studies Were Misleading:

• Benefits reported in prior studies were confined to trials with high risk of bias 1
• When stratified by methodological quality, only low-quality studies showed benefit (RR 0.63), while high-quality studies showed no effect (RR 1.05) 1

Safety Concerns:

• Intravenous NAC for contrast prophylaxis may cause serious adverse effects without proven benefit 3, 4

What DOES Work for Contrast-Induced Nephropathy Prevention

Proven Effective Strategies (Use These Instead):

• Isotonic saline hydration: 1.0-1.5 mL/kg/hour for 3-12 hours before and 6-24 hours after contrast exposure (Class I recommendation) 1, 3
• Minimize contrast volume: Target <350 mL or <4 mL/kg 3
• Use low-osmolar or iso-osmolar contrast media (Class I recommendation) 1, 3
• Consider sodium bicarbonate as alternative to saline: 154 mEq/L at 3 mL/kg for 1 hour pre-procedure, then 1 mL/kg/hour for 6 hours post-procedure 3
• Short-term high-dose statin therapy (Class IIa recommendation) 3

Canadian Nephrology Society Position:

• Since ACT trial publication, updated evidence does not support NAC recommendation for contrast-induced AKI prophylaxis in Canada 1

---

Respiratory Conditions: Mucolytic Use

NAC has established use as a mucolytic agent in respiratory conditions, though this is a secondary indication compared to acetaminophen overdose. 5

• NAC acts as a mucolytic by providing sulfhydryl groups that break disulfide bonds in mucus 5
• Historically used in various respiratory illnesses requiring mucus thinning 5
• This indication is well-established but less critical than its role in acetaminophen toxicity 5

---

Contraindications and Precautions

Relative Contraindications:

• Known hypersensitivity to NAC (anaphylactoid reactions can occur, particularly with IV administration) 1
• Severe asthma (oral NAC may trigger bronchospasm in susceptible patients) 5

Important Caveats:

• For acetaminophen overdose, the benefits of NAC far outweigh risks even in patients with prior reactions—treatment should not be withheld 1, 2
• Anaphylactoid reactions to IV NAC are typically manageable with antihistamines and slowing infusion rate 1

---

Key Clinical Pitfalls to Avoid

1. Never delay NAC in suspected acetaminophen overdose while awaiting levels—start empirically if high suspicion 2
2. Do not use NAC as substitute for adequate hydration in contrast procedures—it provides no benefit and delays proven interventions 1, 4
3. Do not rely on patient history alone for acetaminophen overdose—very high aminotransferases are highly correlated with acetaminophen poisoning even without confirmatory history 2
4. Remember the 8-10 hour window is critical—outcomes dramatically worsen after this timeframe 2
5. Do not withhold NAC in high-risk acetaminophen patients (alcoholics, fasting) even if levels are below standard treatment line 2